These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 546729)

  • 1. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
    Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
    Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum copper levels in malignant lymphomas].
    Peng JF; Wu KC
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):74-6, 124. PubMed ID: 3987447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum copper levels in Hodgkin's disease].
    Cohen Y; Epelboim R; Haim N; Zinder O
    Harefuah; 1984 Mar; 106(6):252-4. PubMed ID: 6745761
    [No Abstract]   [Full Text] [Related]  

  • 11. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
    Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum copper content and ceruloplasmin activity in children with lymphogranulomatosis].
    Dmitrieva LV
    Vopr Okhr Materin Det; 1967 Feb; 12(2):37-40. PubMed ID: 5611374
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpreting serum copper levels in Hodgkin's disease.
    Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
    Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
    Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
    Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood ceruloplasmin levels in acute lymphoblastic leukemia and Hodgkin's disease in childhood].
    Masi M; Vecchi V; Vivarelli F; Paolucci P
    Minerva Pediatr; 1975 Jun; 27(22):1223-8. PubMed ID: 1056499
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlation between blood serum copper levels and ceruloplasmin activity in ischemic heart disease].
    Kondurtsev VA
    Ter Arkh; 1970 Nov; 42(11):30-2. PubMed ID: 5532718
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic changes in red blood cells in malignant lymphomas.
    De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
    Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma.
    Shah I; Chou T; Tapazoglou E; Kessel D
    Scand J Haematol; 1984 Mar; 32(3):332-4. PubMed ID: 6701469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.